Background Most analyses of the economic benefits of smoking cessation consider long-term effects, which are often not of interest to public and private policy makers.
These analyses fail to account for the time course of the short-run cost savings from the rapid decline in risk of acute myocardial infarction (AMI) and stroke.
Methods and Results We estimate the time course of the fall in risk of AMI and stroke after smoking cessation and simulate the impact of a 1% absolute reduction in smoking prevalence on the number of and short-term direct medical costs associated with the prevented AMIs and strokes.
In the first year, there would be 924±679 (mean±SD) fewer hospitalizations for AMI and 538±508 for stroke, resulting in an immediate savings of $44±26 million.
A 7-year program that reduced smoking prevalence by 1% per year would result in a total of 63840±15521 fewer hospitalizations for AMI and 34 261±9133 fewer for stroke, resulting in a total savings of $3.20±0.59 billion in costs, and would prevent=13 100 deaths resulting from AMI that occur before people reach the hospital.
Creating a new nonsmoker reduces anticipated medical costs associated with AMI and stroke by $47 in the first year and by $853 during the next 7 years (discounting 2.5% per year).
Conclusions Although primary prevention of smoking among teenagers is important, reducing adult smoking pays more immediate dividends, both in terms of health improvements and cost savings.
Mots-clés Pascal : Tabagisme, Sevrage, Analyse avantage coût, Economie santé, Evaluation, Infarctus, Myocarde, Accident cérébrovasculaire, Etats Unis, Amérique du Nord, Amérique, Prévention, Facteur risque, Homme, Appareil circulatoire pathologie, Cardiopathie coronaire, Myocarde pathologie, Système nerveux pathologie, Système nerveux central pathologie, Encéphale pathologie, Cérébrovasculaire pathologie, Vaisseau sanguin pathologie
Mots-clés Pascal anglais : Tobacco smoking, Weaning, Cost benefit analysis, Health economy, Evaluation, Infarct, Myocardium, Stroke, United States, North America, America, Prevention, Risk factor, Human, Cardiovascular disease, Coronary heart disease, Myocardial disease, Nervous system diseases, Central nervous system disease, Cerebral disorder, Cerebrovascular disease, Vascular disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0460383
Code Inist : 002B03E. Création : 03/02/1998.